BioSpace News Archive

EVONETIX LTD announced it has been granted patent EP3551331B1 in Europe for its proprietary thermal control technology for DNA synthesis, as well as the design and manufacture of its silicon chips.

Arrayjet, a leading provider of inkjet liquid-handling solutions, introduced Mercury, a new core range of five instruments for ultra-low-volume liquid dispensing.

Ascletis Pharma Inc. announces that the first sale of its ritonavir tablets in Zhejiang Province has been completed.

Sanofi launches its Diversity, Equity & Inclusion Board, the first-of-its-kind in the pharmaceutical industry to feature outside advisors.

Tessa Therapeutics Ltd., a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, announced the appointment of Wilson W. Cheung as its chief financial officer effective April 1, 2022.

Adaptive Phage Therapeutics, Inc., a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, announced that the AMR Action Fund has joined an existing $41 million Series B round as a co-investor.

Venatorx Pharmaceuticals, Inc. announced that it sold shares of its Series C Preferred Stock in a financing led by the AMR Action Fund with participation from existing investors including Abingworth.

Athersys, Inc. announced that its partner, HEALIOS K.K., has provided updates on its two clinical programs evaluating MultiStem® cell therapy, for which Healios has a license and is responsible for the development and commercialization of MultiStem for ischemic stroke and acute respiratory distress syndrome in Japan on an exclusive basis.

Annexon, Inc. announced that Douglas Love, Esq., president & chief executive officer, will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Monday, April 11, 2022 at 3:45 p.m. ET.

Invitae, a leading medical genetics company, announced the full commercial launch of its Neurodevelopmental Disorders package to deliver a robust testing suite that can deliver actionable genetic insights to inform treatment plans for children with developmental disabilities.